MUC16 and neoplasm: Specificity of the observed in vivo tumor uptake was validated by pre-dosing OVCAR3 xenograft animals with 1 mg of unmodified anti-CA125 MAb 24 h prior to injection of 64Cu-labeled anti-CA125 MAb and scFv.